Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Dermatologic Therapy|November 15, 2020
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanomaRyo Amagai, Taku Fujimura, Yusuke Muto, et al.
Case Reports in Oncology|May 18, 2017
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene MonotherapyKayo Tanita, Taku Fujimura, Yota Sato, et al.
Case Reports in Oncology|March 9, 2018
Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical ImiquimodTaku Fujimura, Yumi Kambayashi, Yota Sato, et al.
Case Reports in Dermatology|March 12, 2015
Merkel Cell Carcinoma Concomitant with Invasive Bowen's Disease: Immunohistochemical Investigation of Tumor-Infiltrating LeukocytesHisayuki Tono, Taku Fujimura, Eimei Iwama, et al.
Case Reports in Oncology|February 17, 2017
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by DenosumabSadanori Furudate, Taku Fujimura, Akira Tsukada, et al.
The Journal of Dermatology|March 1, 2018
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapyTaku Fujimura, Yumi Kambayashi, Kayo Tanita, et al.
Anticancer Research|April 5, 2017
Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal ArteryTaku Fujimura, Kazuhiro Takahashi, Yumi Kambayashi, et al.
The Journal of Dermatology|December 4, 2016
Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two casesTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
Case Reports in Dermatology|February 7, 2012
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and BisphosphonateMasaya Ishibashi, Taku Fujimura, Akira Hashimoto, et al.
Oncotarget|October 21, 2017
Phase I study of nivolumab combined with IFN-β for patients with advanced melanomaTaku Fujimura, Takanori Hidaka, Yumi Kambayashi, et al.
Pageof 7